Study of ZnAg Liquid Solution to Treat COVID-19 Symptomatic Participants

NCT04610138 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

296

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19

Interventions

DRUG: CNM-ZnAg
DRUG: Placebo

Sponsor

Clene Nanomedicine

Collaborators

[object Object]
[object Object]